Home Latest Articles
Latest Articles
  • Miao LI, Yanrui GAO, Le KUAI, Bin LI, Ying ZHANG, Mi ZHOU
    World Clinical Drug. 2024, 45(6): 569-574.

    The mutual penetration and influence between the mythological system and traditional Chinese medicine (TCM) culture have jointly formed the unique cultural heritage of TCM. In the process of compiling related prescriptions in traditional Chinese surgery, the author found that "Xian" and "Shen" formula are widely used in clinical practice. By studying the "Xian" and "Shen" culture, this paper discussed the application of representative "Xian" and "Shen" formula in medicine, explored the relationship between the concept of "Xian" and "Shen" and the development of TCM, aimed to open up new ideas for the clinical use of TCM in dermatology.

  • Yiting ZHAO, Haiyan ZHANG, Yajing CAO, Jiandan LI, Xidie YIN, Peiru WANG
    World Clinical Drug. 2024, 45(6): 575-582.

    Artemisinin and its derivatives, including artemether, dihydroartemisinin, artesunate, are natural products extracted from the traditional Chinese plant Artemisia annua L.. Artemisinin and its derivatives have anti-parasitic, anti-viral, antibacterial, antifungal, anti-inflammatory, anticancer, immunomodulatory and other effects, and play an important role in inflammatory skin diseases, photoaging and skin tumors. The main mechanisms of action in the treatment of skin-related diseases include regulating immune cell function, reducing the level of inflammatory factors, regulating cell signaling pathways, and inhibiting the proliferation of tumor cells. This paper described the effects of artemisinin and its derivatives on the above mentioned skin diseases in terms of therapeutic efficacy and mechanism of action, and summarized the relevant action targets and pathways, so as to provide reference for further study of its application.

  • Hui ZHOU, Xin YANG, Xijie WANG, Jing MA
    World Clinical Drug. 2024, 45(6): 583-589.
    Objective

    To investigate the potential of circulating microRNA (miR)-124 as a marker of motor neurotoxicity of aconitine.

    Method

    Forty-two rats were randomly divided into control group, aconitine 0.025 mg/kg (low dose) group and aconitine 0.05 mg/kg (high dose) group, 14 rats in each group, and were given intravenous injection for 14 days. Functional observation combination was used to detect the change of motor behavior. The pathology of brain tissue was observed. The apoptosis of brain cells was detected. Real-time fluorescence quantitative polymerase chain reaction was used to detect the expression of miR-124 in brain and blood. The levels of neuron-specific enolase (NSE) and glial fibrillary acidic protein (GFAP) in blood were detected by enzyme-linked immunosorbent assay.

    Results

    Compared with the control group, the motor behavior of D14 in low dose group and D1 and D14 in high dose group showed easier cage movement, reduced head or body movement, and weakened reflexes after administration (P<0.05). Brain striatum necrosis and glial cell dysplasia were observed in high dose group. The apoptosis of cerebellar granule cell layer and cerebral cortex was increased in low dose and high dose groups, and the expression level of miR-124 in brain tissue was increased (P<0.01). The increase of circulating miR-124 was the earliest in high dose group at 1 h after D1 administration (P<0.01). At 8 h after D1 administration, the increase of circulating NSE and GFAP in high dose group was the earliest (P<0.01).

    Conclusion

    Compared with circulating NSE and GFAP, circulating miR-124 increased earlier in high dose group, which has the potential to detect the motor neurotoxicity of aconitine.

  • Liping ZHAO, Qing SUN, Guirong WANG
    World Clinical Drug. 2024, 45(6): 590-596.
    Objective

    To explore the mechanism of Zhonghe decoction in the intervention of abscess type lymph node tuberculosis.

    Methods

    Cell counting Kit 8 method was used to detect the cytotoxicity of THP-1 in different concentrations of neutralization soup solution. The results were further sequenced by second-generation high-throughput RNA transcriptome sequencing technology, and the differentially expressed genes were screened, and the Gene Ontology functional annotation and pathway analysis of Kyoto Encyclopedia of Genes and Genomes were performed.

    Results

    Zhonghe decoction can reduce the expression of inflammatory factors, inhibit the pathway related to bacterial infection, reduce the response of phosphatidylinositol 3-kinase/protein kinase B signaling pathway, and inhibit the signaling pathway related to pyroptosis and autophagy.

    Conclusion

    Zhonghe decoction may interfere with lymph node tuberculosis by inhibiting cell pyrodeath by inhibiting phosphatidylinositol 3-kinase/protein kinase B signaling pathway.

  • Shuchun LI, Li ZHOU, Lingyan ZHU, Qiong WU, Chenyang LIU, Min CAO
    World Clinical Drug. 2024, 45(6): 597-602.
    Objective

    To investigate the effect of Zhenxin prescription on cardiac function in rats with abdominal aortic coarctation and heart failure (HF).

    Method

    Forty Wistar rats were randomly divided into sham operation group, model group, Zhenxin prescription group and bisoprolol group, with 10 rats in each group. Except the sham operation group, the other groups of rats were treated with abdominal aortic coarctation to establish the HF rat model. Zhenxin prescription group was given 5.6 g/kg/d of Zhenxin prescription suspension, bisoprolol group was given 1 mg/kg/d of bisoprolol fumarate suspension, sham operation group and model group were given the same amount of normal saline intragastric administration for 12 weeks. The contents of echocardiography, left ventricular mass index (LVMI), brain natriuretic peptide (BNP), aldosterone (ALD), angiotensin (Ang) Ⅱ, lactic acid, pyruvic and free fatty acid in all groups were compared.

    Results

    Compared with sham operation group, the serum contents of BNP, ALD, AngⅡ, lactic acid, pyruvate and free fatty acid in model group were significantly increased (P<0.01). Compared with model group, Zhenxin prescription could increase left ventricular ejection fraction, improve myocardial tissue lesion, myocardial fibrosis and LVMI, and significantly decrease serum BNP, ALD, AngⅡ, pyruvate and free fatty acid (P<0.01).

    Conclusion

    Zhenxin prescription can effectively regulate heart function and improve ventricular remodeling in rats with HF, which may be related to reducing the accumulation of serum metabolites.

  • Qiaohui CHEN, Dezhi CHEN, Yanyu XU, Shenglu LIN, Renpei LIANG, Jiakun WANG
    World Clinical Drug. 2024, 45(6): 603-608.
    Objective

    To investigate the effect of shikonin on cyclic adenosine monophosphate (cAMP)/protein kinase (PK) A/cAMP response element binding protein (CREB) signaling pathway on multiple myeloma cells.

    Methods

    The logarithmically grown RPMI-8226 cells were divided into A (blank) group, B (250 μmol/L shikonin) group, C (500 μmol/L shikonin) group, D (1 000 μmol/L) shikonin group, E (SQ22536) group and F (1 000 μmol/L shikonin+SQ22536) group. The apoptosis was observed by Hoechst 33324 staining and flow cytometry. Cell counting kit (CCK)-8 was used to detect cell proliferation. The level of cAMP was detected by enzyme linked immunosorbent assay (ELISA). The expression levels of pathway-related proteins, cyclin D1 and cleaved caspase-3 were detected by western blot.

    Results

    Compared with group A, the proliferation rate and cyclin D1 expression of RPMI-8226 cells in group E were significantly increased, and the apoptosis rate, cAMP level, cleaved caspase-3, p-PKA/PKA, and p-CREB/CREB expressions were significantly decreased (P<0.05). However, cell proliferation rate and cyclin D1 expression were significantly decreased in groups B, C and D, and apoptosis rate, cAMP level, cleaved caspase-3, p-PKA/PKA, and p-CREB/CREB expression were significantly increased, with statistical differences among different concentrations (P<0.05). Compared with group E, cell proliferation rate and cyclin D1 expression in group F were significantly decreased, apoptosis rate, cAMP level, cleaved caspase-3, p-PKA/PKA, and p-CREB/CREB expression were significantly increased in group F (P<0.05). Compared with group D, cell proliferation rate and cyclin D1 expression in group F were significantly increased, apoptosis rate, cAMP level, cleaved caspase-3, p-PKA/PKA, and p-CREB/CREB expression were significantly decreased (P<0.05).

    Conclusion

    Shikonin inhibits the cell proliferation and promote apoptosis of MM cells by regulating the cAMP/PKA/CREB signaling pathway.

  • Suping ZHOU, Zhiyong WU, Jinshun LI, Xu ZHONG
    World Clinical Drug. 2024, 45(6): 609-616.
    Objective

    To investigate the efficacy of sequential administration of sacubitril valsartan and enalapril in the treatment of chronic heart failure (CHF).

    Methods

    A total of 112 CHF patients were randomly divided into the observation group (sequential administration of sacubitril valsartan and enalapril) and the control group (enalapril), with 56 cases in each group. The efficacy, cardiac function, myocardial enzyme spectrum index, serum myeloid differentiation factor (MyD)88, microRNA (miR)-30a, miR-101a, and quality of life were compared between the two groups before and 6 months after treatment.

    Results

    After treatment, the total effective rate in the observation group was higher than that in the control group (96.43% vs 83.93%, P<0.05). Left ventricular end-diastolic diameter, left ventricular end-systolic diameter, creatine kinase, creatine kinase isoenzyme, hydroxybutyrate dehydrogenase, cardiac troponin, N-terminal brain natriuretic peptide, MyD88, miR-30a and score of Minnesota Living with HF Questionnaire were lower than before treatment in the both groups, and the observation group was lower than the control group (P<0.05). Left ventricular ejection fraction, 6 minutes walking distance and miR-101a were higher than before treatment in both groups, and the observation group was higher than control group (P<0.05). There was no significant difference in the incidence of adverse reactions between the two groups (12.50% vs 8.93%, P>0.05).

    Conclusion

    Sequential administration of sacubitril valsartan and enalapril is safe and effective in the treatment of CHF, promoting the improvement of cardiac function and quality of life of patients.

  • Zhongjian LI, Qianqian LIU, Zhen LIU, Zhibing WANG
    World Clinical Drug. 2024, 45(6): 617-623.
    Objective

    To investigate the curative effect of Liangge powder modified prescription on acute respiratory distress syndrome (ARDS) caused by sepsis.

    Methods

    Eighty patients with ARDS caused by sepsis were randomly divided into control group (ulinastatin treatment) and experimental group (Liangge powder modified prescription combined with ulinastatin treatment). The arterial carbon dioxide pressure (PaCO2) and partial pressure of oxygen (PaO2), oxygenation index (PaO2/FiO2), C-reactive protein (CRP), interleukin (IL)-6, tumor necrosis factor (TNF)-α, extravascular lung water index (EVLWI), pulmonary vascular permeability index (PVPI), prognosis and safety were compared between the two groups before and after treatment.

    Results

    After treatment, the total effective rate of experimental group was higher than that of control group (P<0.05). PaO2 and PaO2/FiO2 in the experimental group were higher than before treatment and the control group (P<0.05). The PaCO2, serum CRP, IL-6, TNF-α, EVLWI and PVPI in the experimental group were lower than those of the control group (P<0.05). The mechanical ventilation time and ICU stay time of the experimental group were shorter than those of the control group (P<0.05). The mortality rate of 28 d, acute physiology and chronic health evaluation II and sequential organ failure assessment score after treatment were lower than those of control group (P<0.05). There was no significant difference in the incidence of adverse reactions between the two groups (P>0.05).

    Conclusion

    Liangge powder modified prescription combined with ulinastatin in the treatment of ARDS caused by sepsis can effectively improve the respiratory function of patients, reduce inflammation, correct hypoxemia, shorten mechanical ventilation and hospital stay, reduce mortality, improve prognosis, and have good safety.

  • Yanling QIN, Qiannan LI, Yachai WANG, Qingyi WANG
    World Clinical Drug. 2024, 45(6): 624-630.
    Objective

    To investigate the therapeutic effect of Qingre Jiedu formula combined with desonide cream in the treatment of psoriasis with heat toxin incandescent syndrome and its impacts on inflammatory factors and peripheral blood T lymphocyte subsets.

    Methods

    A total of 96 patients who underwent treatment for psoriasis with heat toxin incandescent syndrome in our hospital from July 2022 to May 2023 were grouped into the experimental group (n=48) and the control group (n=48) by random number table method. The control group was treated with desonide cream, and the experimental group was treated with Qingre Jiedu formula prescription on the basis of the control group. The psoriasis area and severity index (PASI) score, traditional Chinese medicine (TCM) syndrome score, efficacy, serum inflammatory factor levels, T lymphocyte subsets levels, and adverse reactions were compared between the two groups.

    Results

    The total effective rate of the experimental group was higher than that of the control group (79.17% vs 39.58%, P<0.05). After treatment, the PASI, TCM syndrome score, interleukin (IL)-6, tumor necrosis factor-α, nerve growth factor, vascular endothelial growth factor, CD3+, CD4+, and CD4+/CD8+ of both group were reduced compared with those before treatment, and the experimental group was lower than the control group (P<0.05). The IL-10, transforming growth factor-β1, and CD8+ of both group were increased, and those of the experimental group were higher than those of the control group (P<0.05). There was no statistical difference in the incidence of adverse reactions between the two groups (P>0.05).

    Conclusion

    Qingre Jiedu formula prescription combined with desonide cream has a high therapeutic effect on psoriasis with heat toxin incandescent syndrome, and can improve immunity of patients by regulating inflammatory factors and T lymphocyte subsets, with good safety.

  • Min FU, Dong BO, Li DUAN
    World Clinical Drug. 2024, 45(6): 631-635.
    Objective

    To investigate the curative effect of compound Eucommia ulmoides decoction combined with hydroxychloroquine on rheumatoid arthritis (RA).

    Methods

    A total of 98 RA patients admitted to our hospital from July 2020 to October 2022 were randomly divided into control group (hydroxychloroquine) and observation group (hydroxychloroquine+compound Eucommia ulmoides decoction), with 49 patients in each group. The effective rate, disease activity score in 28 joints (DAS28), rheumatoid factor (RF) and C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), disease activity, serum interferon regulatory factor (IRF)4 level, morning stiffness and average grip strength were compared between the two groups after treatment.

    Results

    After treatment, the total effective rate of observation group was higher than that of control group (91.84% vs 71.43%)(P<0.05). The levels of DAS28, IRF4, RF, CRP, ESR, morning stiffness time, joint swelling number and joint tenderness number in both groups were reduced, and the reduction was more significant in observation group than that in control group (P<0.05). The average hand grip strength of both groups was higher than before, and the observation group was higher than that in control group (P<0.05).

    Conclusion

    Compound Eucommia ulmoides decoction combined with hydroxychloroquine can effectively reduce disease activity and improve clinical symptoms in RA patients.

News